United Kingdom Circulatory System Drugs Research
8 comprehensive market analysis studies and research reports on the United Kingdom Circulatory System Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 89 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
8 Healthcare Reports
Categories
Showing 8 of 8 results in Circulatory System Drugs
Pulmonary Arterial Hypertension Market
CAGR: 6.01%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:United Therapeutics, Johnson & Johnson (Actelion Pharmaceuticals Ltd.), Bayer, Gilead Sciences, Pfizer
Blood Disorder Therapeutics Market
CAGR: 6.20%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Takeda Pharmaceuticals, Sanofi, Novo Nordisk, CSL Behring, Pfizer
Chronic Venous Occlusions Market
CAGR: 6.38%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Cardinal Health, Stryker, Boston Scientific, Edward Lifesciences, AngioDynamics
Atherosclerosis Drugs Market
CAGR: 3.14%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Pfizer, AstraZeneca, Merck, Amgen, Regeneron Pharmaceuticals
Global Myeloproliferative Disorders (MPD) Treatment Market
CAGR: 4.9%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Novartis, Bristol-Myers Squibb, Incyte, Takeda Pharmaceuticals, Viatris
Global Hematologic Malignancies Treatment Market
CAGR: 7.77%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Pfizer, F. Hoffmann-LA Roche ltd, Abbvie, Bristol-Myers Squibb, Sanofi
Hemostasis Products Market
CAGR: 5.65%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Abbott Laboratories, Baxter, Medtronic, Becton Dickinson (BD), CSL Behring
Thrombosis Drugs Market
CAGR: 8%
Study Period: 2019 - 2030
Country Covered: United Kingdom
Major Players:Boehringer Ingelheim, Johnson & Johnson, Sanofi, Pfizer, Laurus Labs
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
